Your browser doesn't support javascript.
loading
Netrin-1 and its receptor DCC modulate survival and death of dopamine neurons and Parkinson's disease features.
Jasmin, Mélissa; Ahn, Eun Hee; Voutilainen, Merja H; Fombonne, Joanna; Guix, Catherine; Viljakainen, Tuulikki; Kang, Seong Su; Yu, Li-Ying; Saarma, Mart; Mehlen, Patrick; Ye, Keqiang.
Affiliation
  • Jasmin M; Apoptosis, Cancer and Development Laboratory - Equipe labellisée 'La Ligue', LabEx DEVweCAN, Centre de Recherche en Cancérologie de Lyon, INSERM U1052-CNRS UMR5286, Centre Léon Bérard, Université de Lyon, Université de Lyon1, Lyon, France.
  • Ahn EH; Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA, USA.
  • Voutilainen MH; Institute of Biotechnology, HiLIFE, University of Helsinki, Helsinki, Finland.
  • Fombonne J; Division of Pharmacology and Pharmacotherapy, Faculty of Pharmacy, University of Helsinki, Helsinki, Finland.
  • Guix C; Apoptosis, Cancer and Development Laboratory - Equipe labellisée 'La Ligue', LabEx DEVweCAN, Centre de Recherche en Cancérologie de Lyon, INSERM U1052-CNRS UMR5286, Centre Léon Bérard, Université de Lyon, Université de Lyon1, Lyon, France.
  • Viljakainen T; Apoptosis, Cancer and Development Laboratory - Equipe labellisée 'La Ligue', LabEx DEVweCAN, Centre de Recherche en Cancérologie de Lyon, INSERM U1052-CNRS UMR5286, Centre Léon Bérard, Université de Lyon, Université de Lyon1, Lyon, France.
  • Kang SS; Institute of Biotechnology, HiLIFE, University of Helsinki, Helsinki, Finland.
  • Yu LY; Division of Pharmacology and Pharmacotherapy, Faculty of Pharmacy, University of Helsinki, Helsinki, Finland.
  • Saarma M; Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA, USA.
  • Mehlen P; Institute of Biotechnology, HiLIFE, University of Helsinki, Helsinki, Finland.
  • Ye K; Institute of Biotechnology, HiLIFE, University of Helsinki, Helsinki, Finland.
EMBO J ; 40(3): e105537, 2021 02 01.
Article in En | MEDLINE | ID: mdl-33351190
ABSTRACT
The netrin-1/DCC ligand/receptor pair has key roles in central nervous system (CNS) development, mediating axonal, and neuronal navigation. Although expression of netrin-1 and DCC is maintained in the adult brain, little is known about their role in mature neurons. Notably, netrin-1 is highly expressed in the adult substantia nigra, leading us to investigate a role of the netrin-1/DCC pair in adult nigral neuron fate. Here, we show that silencing netrin-1 in the adult substantia nigra of mice induces DCC cleavage and a significant loss of dopamine neurons, resulting in motor deficits. Because loss of adult dopamine neurons and motor impairments are features of Parkinson's disease (PD), we studied the potential impact of netrin-1 in different animal models of PD. We demonstrate that both overexpression of netrin-1 and brain administration of recombinant netrin-1 are neuroprotective and neurorestorative in mouse and rat models of PD. Of interest, we observed that netrin-1 levels are significantly reduced in PD patient brain samples. These results highlight the key role of netrin-1 in adult dopamine neuron fate, and the therapeutic potential of targeting netrin-1 signaling in PD.
Subject(s)
Key words

Full text: 1 Database: MEDLINE Main subject: Parkinson Disease / Substantia Nigra / Netrin-1 / DCC Receptor Type of study: Etiology_studies Limits: Animals / Female / Humans / Male Language: En Journal: EMBO J Year: 2021 Type: Article Affiliation country: France

Full text: 1 Database: MEDLINE Main subject: Parkinson Disease / Substantia Nigra / Netrin-1 / DCC Receptor Type of study: Etiology_studies Limits: Animals / Female / Humans / Male Language: En Journal: EMBO J Year: 2021 Type: Article Affiliation country: France